admin | Beating ALS

[blog-news]

NeuroSense Enrolls First Patient in Phase IIb ALS Trial for its Combination Therapy PrimeC

NeuroSense Enrolls First Patient in Phase IIb ALS Trial for its Combination Therapy PrimeC

by admin | Jun 5, 2022 | Blog, Clinical trials

... Read More | Share it now!

Antisense oligonucleotide silencing

Antisense oligonucleotide silencing

by admin | Jun 5, 2022 | Blog, Clinical trials, News

... Read More | Share it now!

Mitochondrial dysregulation

Mitochondrial dysregulation

by admin | Jun 4, 2022 | Blog, News

... Read More | Share it now!

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases

by admin | Jun 4, 2022 | Blog

... Read More | Share it now!

Ultomiris

by admin | Jun 2, 2022 | Clinical trials

... Read More | Share it now!

« Older Entries

Next Entries »